Eliem Therapeutics, Inc. (ELYM)
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures that is in Phase I clinical trial. The company also develops preclinical pipeline programs, such as Kv7 Program for pain, epilepsy, and depression; and Anxiolytic for the treatment of generalized anxiety disorder. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington.
$558.68M
Dr. Andrew Levin M.D., Ph.D.
43.00
Redmond, WA
Aug 06, 2021
-3.75
$-2.22
59.65
60.41
0.00%
-3.91
-0.04
1.13
0.00
60.41
-28.40%
-47.03%
Similar stocks (12)
PepGen Inc.
PEPG
Rezolute, Inc.
RZLT
Acrivon Therapeutics, Inc. Common Stock
ACRV
Shattuck Labs, Inc.
STTK
Century Therapeutics, Inc.
IPSC
MediciNova, Inc.
MNOV
PMV Pharmaceuticals, Inc.
PMVP
Champions Oncology, Inc.
CSBR
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
HCW Biologics Inc.
HCWB
ETF Exposure (18)
iShares Micro-Cap ETF
IWC
0.01458%
iShares Russell 2000 Value ETF
IWN
0.00484%
iShares Russell 2000 ETF
IWM
0.00177%
ProShares Ultra Russell2000
UWM
8.166702351827304e-4%
ProShares UltraPro Russell2000
URTY
4.036587883950587e-4%
ProShares Hedge Replication ETF
HDG
3.5332337235005677e-4%
Dimensional U.S. Small Cap ETF
DFAS
3.0868e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.4474e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (12)
PepGen Inc.
PEPG
Rezolute, Inc.
RZLT
Acrivon Therapeutics, Inc. Common Stock
ACRV
Shattuck Labs, Inc.
STTK
Century Therapeutics, Inc.
IPSC
MediciNova, Inc.
MNOV
PMV Pharmaceuticals, Inc.
PMVP
Champions Oncology, Inc.
CSBR
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
HCW Biologics Inc.
HCWB
ETF Exposure (18)
iShares Micro-Cap ETF
IWC
0.01458%
iShares Russell 2000 Value ETF
IWN
0.00484%
iShares Russell 2000 ETF
IWM
0.00177%
ProShares Ultra Russell2000
UWM
8.166702351827304e-4%
ProShares UltraPro Russell2000
URTY
4.036587883950587e-4%
ProShares Hedge Replication ETF
HDG
3.5332337235005677e-4%
Dimensional U.S. Small Cap ETF
DFAS
3.0868e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.4474e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Index Fund
VTWO
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%
Vanguard Extended Market Index Fund
VXF
0%